{
    "organizations": [],
    "uuid": "3c5ea223584ab3ebf1eefe00f018b4da1b53a7cd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-moberg-pharma-q4-ebitda-above-expe/brief-moberg-pharma-q4-ebitda-above-expectations-at-sek-27-0-million-idUSFWN1Q302F",
    "ord_in_thread": 0,
    "title": "Moberg Pharma Q4 EBITDA Above Expectations At SEK 27.0 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - MOBERG PHARMA AB (PUBL):\n* Q4 NET REVENUE SEK 90.1 MILLION (89.4) * Q4 EBITDA SEK 27.0 MILLION (12.0) * Q4 OPERATING PROFIT (EBIT) SEK 17.6 MILLION (7.1) * Q4 EBITDA SEK 27.0 MILLION (REUTERS POLL: SEK 19.6 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-13T15:19:00.000+02:00",
    "crawled": "2018-02-14T12:25:32.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "moberg",
        "pharma",
        "ab",
        "publ",
        "q4",
        "net",
        "revenue",
        "sek",
        "million",
        "q4",
        "ebitda",
        "sek",
        "million",
        "q4",
        "operating",
        "profit",
        "ebit",
        "sek",
        "million",
        "q4",
        "ebitda",
        "sek",
        "million",
        "reuters",
        "poll",
        "sek",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}